Clinical Trial Results

Showing: All studies [change]
Condition: Diabetes Location: Las Vegas, Nevada 25 trials found
New Search
Filter
Trial Phase
Study Type
A Study of the Effect of ZT-01 on Night-time Hypoglycemia in Type 1 Diabetes
PHASE2INTERVENTIONAL Birmingham, Alabama +4 more
RECRUITING
A Randomized Comparison of Stage-Based Care Versus Risk Factor-Based Care for Prevention of Cardiovascular Events
NAINTERVENTIONAL Chandler, Arizona +4 more
RECRUITING
A Study of Lower Radiotherapy Dose to Treat Children With CNS Germinoma
PHASE2INTERVENTIONAL Mobile, Alabama +4 more
RECRUITING
How a Mediterranean Diet With Potatoes Impacts Heart and Metabolic Health in Adults With Pre-Diabetes
NAINTERVENTIONAL Las Vegas, Nevada +1 more
RECRUITING
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
PHASE3INTERVENTIONAL Anniston, Alabama +4 more
RECRUITING
A Study of Macupatide (LY3532226) and Eloralintide (LY3841136), Alone or in Combination, in Adults With Obesity or Overweight and With Type 2 Diabetes
PHASE2INTERVENTIONAL Gilbert, Arizona +4 more
RECRUITING
Efficacy and Safety of Ribupatide in Participants Living With Obesity or Overweight With Weight-Related Comorbidities Who Do Not Have Diabetes
PHASE3INTERVENTIONAL Anniston, Alabama +4 more
RECRUITING
Efficacy and Safety of Ribupatide Administered Once Weekly in Participants Living With Obesity or Overweight and Diabetes
PHASE3INTERVENTIONAL Cullman, Alabama +4 more
RECRUITING
Efficacy and Safety of Ribupatide Administered Once Weekly Compared With Semaglutide and Placebo in Participants Living With Obesity Who Do Not Have Diabetes
PHASE3INTERVENTIONAL Glendale, Arizona +4 more
RECRUITING
Trial Against INtractable Type 2 Diabetes (CAPTAIN-T2D)
PHASE2INTERVENTIONAL Chandler, Arizona +4 more
RECRUITING
A Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without Type 2 Diabetes
PHASE3INTERVENTIONAL Tuscaloosa, Alabama +4 more
RECRUITING
Phase 2 Trial of Icovamenib in Participants With Type 2 Diabetes Mellitus Who Are Not Achieving Glycemic Targets While Using GLP-1-Based Therapy
PHASE2INTERVENTIONAL Birmingham, Alabama +4 more
RECRUITING
Study to Evaluate HM15275 in Subjects With Type 2 Diabetes Mellitus
PHASE2INTERVENTIONAL Mesa, Arizona +4 more
RECRUITING
HP-211 Safety and Proof of Concept Dose Ranging Study in Patients With Type 2 Diabetes
PHASE2INTERVENTIONAL Canoga Park, California +4 more
RECRUITING
A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or Overweight
PHASE2INTERVENTIONAL Chandler, Arizona +4 more
RECRUITING
A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)
PHASE3INTERVENTIONAL Birmingham, Alabama +4 more
RECRUITING
A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Alone or in Combination With Dapagliflozin Compared With Placebo in Adults With Type 2 Diabetes Mellitus
PHASE3INTERVENTIONAL Birmingham, Alabama +4 more
RECRUITING
A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Compared With Placebo in Adults With Type 2 Diabetes Mellitus and Impaired Renal Function on Background Dapagliflozin
PHASE3INTERVENTIONAL Sun City, Arizona +4 more
RECRUITING
A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus
PHASE3INTERVENTIONAL Birmingham, Alabama +4 more
RECRUITING
Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-2-EXTENSION)
PHASE3INTERVENTIONAL Gilbert, Arizona +4 more
RECRUITING
A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes
PHASE3INTERVENTIONAL Birmingham, Alabama +4 more
RECRUITING
A Study to Evaluate Effect of AZD6234 as an Adjunct to Incretin-based Therapies in Adult Participants With Obesity or Overweight With Weight-related Comorbidity With or Without Type 2 Diabetes Mellitus
PHASE3INTERVENTIONAL Escondido, California +4 more
RECRUITING
A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event
PHASE2INTERVENTIONAL Huntsville, Alabama +4 more
RECRUITING
A Study to Evaluate Effect of AZD6234 in Adult Participants With Obesity or Overweight With Weight-related Comorbidity Without Type 2 Diabetes Mellitus
PHASE3INTERVENTIONAL Dothan, Alabama +4 more
RECRUITING
AMBITION 7: A Research Study Investigating How Well Zenagamtide Lowers Blood Sugar and Body Weight Compared to Insulin Glargine in People With Type 2 Diabetes and Increased Risk of Diseases That Affect the Heart and Blood Vessels Treated With 1-3 Other Diabetes Medications
PHASE3INTERVENTIONAL Birmingham, Alabama +4 more
RECRUITING
Filter Trials
Trial Phase
Study Type